Click on image to view ad details and full-size version on AdPharm

To see all of the ads from this campaign, click here
To see all of this brand’s ads on AdPharm, click here

For the treatment of adults with major depressive disorder
SNRI Therapy… For your managed care formulary
Predictable kinetics
Predictable Dacon
Predictable cost

Desvenlafaxine succinate, marketed under the name Pristiq, is an antidepressant of the serotonin-norepinephrine reuptake inhibitor class from Wyeth. It is a metabolite of venlafaxine (Effexor). Although Wyeth touts the notion that Pristiq is being targeted as the first non-hormonal based treatment for menopause, in fact, the anticonvulsant medication gabapentin already owns this distinction.[

More on Wikipedia

Brand name: Pristiq
Generic name/category: desvenlafaxine
Company: Wyeth
Country/Market: USA, North America
Indication(s)/use: Major Depressive Disorder (MDD)
Target: Healthcare Professionals (HCP)
Tagline: Think beyond start
Publication: Pharmacy And Therapeutics May 2009